Rbm24, a target of p53, is necessary for proper expression of p53 and heart development

被引:0
|
作者
Min Zhang
Yanhong Zhang
Enshun Xu
Shakur Mohibi
Danielle Michelle de Anda
Yuqian Jiang
Jin Zhang
Xinbin Chen
机构
[1] University of California at Davis,Comparative Oncology Laboratory, Schools of Veterinary Medicine and Medicine
[2] Huazhong Agricultural University,College of Life Science and Technology
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Activation of p53-dependent apoptosis is critical for tumor suppression but aberrant activation of p53 also leads to developmental defects and heart failure. Here, we found that Rbm24 RNA-binding protein, a target of p53, regulates p53 mRNA translation. Mechanistically, we found that through binding to p53 mRNA and interaction with translation initiation factor eIF4E, Rbm24 prevents eIF4E from binding to p53 mRNA and inhibits the assembly of translation initiation complex. Importantly, we showed that mice deficient in Rbm24 die in utero due to the endocardial cushion defect in the heart at least in part due to aberrant activation of p53-dependent apoptosis. We also showed that the heart developmental defect in Rbm24-null mice can be partially rescued by p53 deficiency through decreased apoptosis in the heart. Together, we postulate that the p53-Rbm24 loop is critical for the heart development and may be explored for mitigating congenital heart diseases and heart failure.
引用
收藏
页码:1118 / 1130
页数:12
相关论文
共 50 条
  • [1] Rbm24, a target of p53, is necessary for proper expression of p53 and heart development
    Zhang, Min
    Zhang, Yanhong
    Xu, Enshun
    Mohibi, Shakur
    de Anda, Danielle Michelle
    Jiang, Yuqian
    Zhang, Jin
    Chen, Xinbin
    CELL DEATH AND DIFFERENTIATION, 2018, 25 (06): : 1118 - 1130
  • [2] Rbm24, an RNA-binding Protein and a Target of p53, Regulates p21 Expression via mRNA Stability
    Jiang, Yuqian
    Zhang, Min
    Qian, Yingjuan
    Xu, Enshun
    Zhang, Jin
    Chen, Xinbin
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (06) : 3164 - 3175
  • [3] P53: A Key Target in the Development of Osteoarthritis
    Wentao Ma
    Xiaoqian Tan
    Zhongcheng Xie
    Jiang Yu
    Pin Li
    Xiaoyan Lin
    Siyu Ouyang
    Zhiyang Liu
    Qin Hou
    Nan Xie
    Tianhong Peng
    Liang Li
    Zhu Dai
    Xi Chen
    Wei Xie
    Molecular Biotechnology, 2024, 66 : 1 - 10
  • [4] P53: A Key Target in the Development of Osteoarthritis
    Ma, Wentao
    Tan, Xiaoqian
    Xie, Zhongcheng
    Yu, Jiang
    Li, Pin
    Lin, Xiaoyan
    Ouyang, Siyu
    Liu, Zhiyang
    Hou, Qin
    Xie, Nan
    Peng, Tianhong
    Li, Liang
    Dai, Zhu
    Chen, Xi
    Xie, Wei
    MOLECULAR BIOTECHNOLOGY, 2024, 66 (01) : 1 - 10
  • [5] Modulation of alternative splicing contributes to cancer development: focusing on p53 isoforms, p53β and p53γ
    Solomon, H.
    Sharon, M.
    Rotter, V.
    CELL DEATH AND DIFFERENTIATION, 2014, 21 (09): : 1347 - 1349
  • [6] Modulation of alternative splicing contributes to cancer development: focusing on p53 isoforms, p53β and p53γ
    H Solomon
    M Sharon
    V Rotter
    Cell Death & Differentiation, 2014, 21 : 1347 - 1349
  • [7] Role of p53 Serine 46 in p53 Target Gene Regulation
    Smeenk, Leonie
    van Heeringen, Simon J.
    Koeppel, Max
    Gilbert, Bianca
    Janssen-Megens, Eva
    Stunnenberg, Hendrik G.
    Lohrum, Marion
    PLOS ONE, 2011, 6 (03):
  • [8] A Neat target of p53
    Eytan Zlotorynski
    Nature Reviews Molecular Cell Biology, 2017, 18 : 532 - 532
  • [9] PML is a direct p53 target that modulates p53 effector functions
    de Stanchina, E
    Querido, E
    Narita, M
    Davuluri, RV
    Pandolfi, PP
    Ferbeyre, G
    Lowe, SW
    MOLECULAR CELL, 2004, 13 (04) : 523 - 535
  • [10] p53 as a therapeutic target
    Staples, O. D.
    Steele, R. J. C.
    Lain, S.
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2008, 6 (04): : 240 - 243